SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The… Read more
SMS Pharmaceuticals Limited (SMSPHARMA) - Total Liabilities
Latest total liabilities as of September 2025: ₹5.47 Billion INR
Based on the latest financial reports, SMS Pharmaceuticals Limited (SMSPHARMA) has total liabilities worth ₹5.47 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SMS Pharmaceuticals Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how SMS Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
SMS Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of SMS Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sunflag Iron And Steel Company Limited
NSE:SUNFLAG
|
India | ₹23.28 Billion |
|
South Atlantic Bancshares Inc
OTCQX:SABK
|
USA | $1.79 Billion |
|
Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS
IS:LKMNH
|
Turkey | TL2.76 Billion |
|
Sivers IMA Holding AB
ST:SIVE
|
Sweden | Skr374.60 Million |
|
Zhejiang Prulde Electric Appliance Co. Ltd. A
SHE:301353
|
China | CN¥233.49 Million |
|
Freightcar America Inc
NASDAQ:RAIL
|
USA | $431.63 Million |
|
Synalloy Corporation
NASDAQ:ACNT
|
USA | $24.95 Million |
Liability Composition Analysis (2005–2025)
This chart breaks down SMS Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.27 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SMS Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SMS Pharmaceuticals Limited (2005–2025)
The table below shows the annual total liabilities of SMS Pharmaceuticals Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹5.13 Billion | +3.07% |
| 2024-03-31 | ₹4.98 Billion | +18.77% |
| 2023-03-31 | ₹4.19 Billion | +7.67% |
| 2022-03-31 | ₹3.89 Billion | -3.10% |
| 2021-03-31 | ₹4.02 Billion | +54.69% |
| 2020-03-31 | ₹2.60 Billion | +9.62% |
| 2019-03-31 | ₹2.37 Billion | +8.65% |
| 2018-03-31 | ₹2.18 Billion | -39.21% |
| 2017-03-31 | ₹3.59 Billion | -0.92% |
| 2016-03-31 | ₹3.62 Billion | +26.37% |
| 2015-03-31 | ₹2.86 Billion | -0.35% |
| 2014-03-31 | ₹2.87 Billion | +26.49% |
| 2013-03-31 | ₹2.27 Billion | -16.04% |
| 2012-03-31 | ₹2.71 Billion | +6.93% |
| 2011-03-31 | ₹2.53 Billion | +14.09% |
| 2010-03-31 | ₹2.22 Billion | +19.15% |
| 2009-03-31 | ₹1.86 Billion | +31.12% |
| 2008-03-31 | ₹1.42 Billion | +24.19% |
| 2007-03-31 | ₹1.14 Billion | +3.57% |
| 2006-03-31 | ₹1.10 Billion | +4.47% |
| 2005-03-31 | ₹1.06 Billion | -- |